{"transactions":[{"id":720812,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T20:10:10.000Z","date":"2026-06-29","kind":"exercise","planned":false,"acquired":false,"shares":215687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares underlying the option vested on January 19, 2025 and the remaining shares have vested or will vest in equal monthly installments thereafter over the following 36 months, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":141313,"derivative":{"exercise_price":1.91,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":215687},"source":{"system":"sec-edgar","filing":"0001213900-26-074238","document":"marketforms-73501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026074238/marketforms-73501.xml","form_type":"4"}},{"id":720811,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:10:10.000Z","date":"2026-06-30","kind":"gift","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":691832,"source":{"system":"sec-edgar","filing":"0001213900-26-074238","document":"marketforms-73501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026074238/marketforms-73501.xml","form_type":"4"}},{"id":720810,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:10:10.000Z","date":"2026-06-30","kind":"gift","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":696832,"source":{"system":"sec-edgar","filing":"0001213900-26-074238","document":"marketforms-73501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026074238/marketforms-73501.xml","form_type":"4"}},{"id":720809,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:10:10.000Z","date":"2026-06-30","kind":"gift","planned":false,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":700832,"source":{"system":"sec-edgar","filing":"0001213900-26-074238","document":"marketforms-73501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026074238/marketforms-73501.xml","form_type":"4"}},{"id":720808,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:10:10.000Z","date":"2026-06-30","kind":"gift","planned":false,"acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":707832,"source":{"system":"sec-edgar","filing":"0001213900-26-074238","document":"marketforms-73501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026074238/marketforms-73501.xml","form_type":"4"}},{"id":720807,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:10:10.000Z","date":"2026-06-29","kind":"sale","planned":false,"acquired":false,"shares":215687,"price":4.09,"value":882159.83,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.03 to $4.14, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":721832,"source":{"system":"sec-edgar","filing":"0001213900-26-074238","document":"marketforms-73501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026074238/marketforms-73501.xml","form_type":"4"}},{"id":720806,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T20:10:10.000Z","date":"2026-06-29","kind":"exercise","planned":false,"acquired":true,"shares":215687,"price":1.91,"value":411962.17,"ownership":{"direct":true},"balance_after":937519,"source":{"system":"sec-edgar","filing":"0001213900-26-074238","document":"marketforms-73501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026074238/marketforms-73501.xml","form_type":"4"}},{"id":929847,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-27T21:10:07.000Z","date":"2026-01-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":8732,"price":6.67,"value":58242.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025."}],"balance_after":1021832,"source":{"system":"sec-edgar","filing":"0001213900-26-008224","document":"marketforms-71934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026008224/marketforms-71934.xml","form_type":"4"}},{"id":933236,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-22T21:30:26.000Z","date":"2026-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":16322,"price":5.6,"value":91403.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024."}],"balance_after":1030564,"source":{"system":"sec-edgar","filing":"0001213900-26-006711","document":"marketforms-71772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026006711/marketforms-71772.xml","form_type":"4"}},{"id":934051,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-21T21:36:25.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":524000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":524000,"derivative":{"exercise_price":5.01,"expiration_date":"2036-01-15","underlying":"Common Stock","underlying_shares":524000},"source":{"system":"sec-edgar","filing":"0001213900-26-006226","document":"marketforms-71894.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026006226/marketforms-71894.xml","form_type":"4"}},{"id":934050,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-21T21:36:25.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":87000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":1046886,"source":{"system":"sec-edgar","filing":"0001213900-26-006226","document":"marketforms-71894.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026006226/marketforms-71894.xml","form_type":"4"}},{"id":1091175,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-07-07T20:10:10.000Z","date":"2025-06-24","kind":"gift","planned":false,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"On June 24, 2025, the reporting person transferred 300,000 shares of common stock to The Samhold Family Trust for no consideration. Members of the reporting person's immediate family are the sole beneficiaries of the trust and a member of the reporting person's immediate family serves as a trustee thereof. The reporting person remains the beneficial owner of the securities held by the trust."}],"balance_after":659886,"source":{"system":"sec-edgar","filing":"0001213900-25-061772","document":"marketforms-70060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025061772/marketforms-70060.xml","form_type":"4"}},{"id":1099096,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-30T20:10:10.000Z","date":"2025-06-27","kind":"gift","planned":false,"acquired":false,"shares":3367,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":959886,"source":{"system":"sec-edgar","filing":"0001213900-25-059655","document":"marketforms-69999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025059655/marketforms-69999.xml","form_type":"4"}},{"id":1099095,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-30T20:10:10.000Z","date":"2025-06-27","kind":"gift","planned":false,"acquired":false,"shares":10200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":963253,"source":{"system":"sec-edgar","filing":"0001213900-25-059655","document":"marketforms-69999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025059655/marketforms-69999.xml","form_type":"4"}},{"id":1099094,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-30T20:10:10.000Z","date":"2025-06-26","kind":"gift","planned":false,"acquired":false,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":973453,"source":{"system":"sec-edgar","filing":"0001213900-25-059655","document":"marketforms-69999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025059655/marketforms-69999.xml","form_type":"4"}},{"id":1099093,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-30T20:10:10.000Z","date":"2025-06-26","kind":"gift","planned":false,"acquired":false,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":976853,"source":{"system":"sec-edgar","filing":"0001213900-25-059655","document":"marketforms-69999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025059655/marketforms-69999.xml","form_type":"4"}},{"id":1292875,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-28T21:05:17.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":387000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 24, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":387000,"derivative":{"exercise_price":4.53,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":387000},"source":{"system":"sec-edgar","filing":"0001213900-25-007533","document":"marketforms-67930.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025007533/marketforms-67930.xml","form_type":"4"}},{"id":1292874,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-01-28T21:05:17.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 24, 2025."}],"balance_after":994022,"source":{"system":"sec-edgar","filing":"0001213900-25-007533","document":"marketforms-67930.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025007533/marketforms-67930.xml","form_type":"4"}},{"id":1296242,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-01-23T21:05:19.000Z","date":"2025-01-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":15469,"price":4.76,"value":73632.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024."}],"balance_after":913553,"source":{"system":"sec-edgar","filing":"0001213900-25-005962","document":"marketforms-67893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025005962/marketforms-67893.xml","form_type":"4"}},{"id":1307661,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-01-07T21:20:13.000Z","date":"2025-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":6479,"price":6.14,"value":39781.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022."}],"balance_after":929022,"source":{"system":"sec-edgar","filing":"0001213900-25-001648","document":"marketforms-67735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025001648/marketforms-67735.xml","form_type":"4"}},{"id":1418846,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-08-30T20:05:11.000Z","date":"2024-08-28","kind":"gift","planned":false,"acquired":false,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":935501,"source":{"system":"sec-edgar","filing":"0001213900-24-074514","document":"marketforms-66787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024074514/marketforms-66787.xml","form_type":"4"}},{"id":1418845,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-08-30T20:05:11.000Z","date":"2024-08-28","kind":"gift","planned":false,"acquired":false,"shares":5263,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":938801,"source":{"system":"sec-edgar","filing":"0001213900-24-074514","document":"marketforms-66787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024074514/marketforms-66787.xml","form_type":"4"}},{"id":1672790,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-23T21:05:31.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":357000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":357000,"derivative":{"exercise_price":1.91,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":357000},"source":{"system":"sec-edgar","filing":"0001213900-24-005725","document":"marketforms-64334.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024005725/marketforms-64334.xml","form_type":"4"}},{"id":1672789,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-01-23T21:05:31.000Z","date":"2024-01-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":7803,"price":1.91,"value":14903.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2023."}],"balance_after":944064,"source":{"system":"sec-edgar","filing":"0001213900-24-005725","document":"marketforms-64334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024005725/marketforms-64334.xml","form_type":"4"}},{"id":1672788,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-01-23T21:05:31.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":59000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024."}],"balance_after":951867,"source":{"system":"sec-edgar","filing":"0001213900-24-005725","document":"marketforms-64334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024005725/marketforms-64334.xml","form_type":"4"}},{"id":1679833,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-01-12T21:05:40.000Z","date":"2024-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":5746,"price":2.39,"value":13732.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 10, 2020."}],"balance_after":892867,"source":{"system":"sec-edgar","filing":"0001213900-24-003336","document":"marketforms-64052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024003336/marketforms-64052.xml","form_type":"4"}},{"id":1685266,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-01-05T21:30:46.000Z","date":"2024-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":5840,"price":2.17,"value":12672.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022."}],"balance_after":898613,"source":{"system":"sec-edgar","filing":"0001213900-24-001541","document":"marketforms-63998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390024001541/marketforms-63998.xml","form_type":"4"}},{"id":1843303,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-06-27T23:26:20.000Z","date":"2023-06-27","kind":"gift","planned":false,"acquired":false,"shares":7420,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":904453,"source":{"system":"sec-edgar","filing":"0001213900-23-052231","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390023052231/ownership.xml","form_type":"4"}},{"id":1843302,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-06-27T23:26:20.000Z","date":"2023-06-23","kind":"gift","planned":false,"acquired":false,"shares":1890,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":911873,"source":{"system":"sec-edgar","filing":"0001213900-23-052231","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390023052231/ownership.xml","form_type":"4"}},{"id":2022366,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-02-10T21:05:18.000Z","date":"2022-06-27","kind":"gift","acquired":false,"shares":4519,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":913763,"source":{"system":"sec-edgar","filing":"0001213900-23-010283","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390023010283/ownership.xml","form_type":"5"}},{"id":2049477,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-20T21:00:14.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":307500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 19, 2023 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":307500,"derivative":{"exercise_price":3.02,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":307500},"source":{"system":"sec-edgar","filing":"0001213900-23-004081","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390023004081/ownership.xml","form_type":"4"}},{"id":2049476,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-01-20T21:00:14.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":51300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2023."}],"balance_after":918282,"source":{"system":"sec-edgar","filing":"0001213900-23-004081","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390023004081/ownership.xml","form_type":"4"}},{"id":2056357,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-01-11T21:03:47.000Z","date":"2023-01-10","kind":"tax_withholding","acquired":false,"shares":5855,"price":3,"value":17565.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 10, 2020."}],"balance_after":866982,"source":{"system":"sec-edgar","filing":"0001213900-23-002261","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390023002261/ownership.xml","form_type":"4"}},{"id":2066186,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-01-04T21:25:47.000Z","date":"2023-01-03","kind":"tax_withholding","acquired":false,"shares":6604,"price":2.8,"value":18491.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022."}],"balance_after":872837,"source":{"system":"sec-edgar","filing":"0001213900-23-000854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390023000854/ownership.xml","form_type":"4"}},{"id":2185384,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-08-15T21:49:04.000Z","date":"2022-08-11","kind":"purchase","acquired":true,"shares":9065,"price":3.84,"value":34809.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.66 to $3.93, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":879441,"source":{"system":"sec-edgar","filing":"0001213900-22-048179","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390022048179/ownership.xml","form_type":"4"}},{"id":2401173,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-02-11T21:49:10.000Z","date":"2021-06-29","kind":"gift","acquired":false,"shares":513,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":870376,"source":{"system":"sec-edgar","filing":"0001209191-22-008912","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919122008912/doc5.xml","form_type":"5"}},{"id":2401172,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-02-11T21:49:10.000Z","date":"2021-06-29","kind":"gift","acquired":false,"shares":1536,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":870889,"source":{"system":"sec-edgar","filing":"0001209191-22-008912","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919122008912/doc5.xml","form_type":"5"}},{"id":2436558,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-01-12T22:18:49.000Z","date":"2022-01-10","kind":"tax_withholding","acquired":false,"shares":5080,"price":6.27,"value":31851.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted\nto the Reporting Person on January 10, 2020."}],"balance_after":872425,"source":{"system":"sec-edgar","filing":"0001209191-22-003088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919122003088/doc4.xml","form_type":"4"}},{"id":2443092,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T21:36:34.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":253500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 3, 2022 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":253500,"derivative":{"exercise_price":6.9,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":253500},"source":{"system":"sec-edgar","filing":"0001209191-22-001719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919122001719/doc4.xml","form_type":"4"}},{"id":2443091,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-01-05T21:36:34.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":42300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock.  The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 3, 2022."}],"balance_after":877505,"source":{"system":"sec-edgar","filing":"0001209191-22-001719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919122001719/doc4.xml","form_type":"4"}},{"id":2900444,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-21T20:03:23.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":202000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vest on the one year anniversary of January 19, 2021 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":202000,"derivative":{"exercise_price":19.82,"expiration_date":"2031-01-18","underlying":"Common Stock","underlying_shares":202000},"source":{"system":"sec-edgar","filing":"0001209191-21-004651","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919121004651/doc4.xml","form_type":"4"}},{"id":2908009,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-01-13T22:16:09.000Z","date":"2021-01-11","kind":"tax_withholding","acquired":false,"shares":5069,"price":21.16,"value":107260.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted\nto the Reporting Person on January 10, 2020."}],"balance_after":835205,"source":{"system":"sec-edgar","filing":"0001209191-21-003445","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919121003445/doc4.xml","form_type":"4"}},{"id":3084201,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-13T18:56:38.000Z","date":"2020-07-10","kind":"grant","acquired":true,"shares":111250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vest on the one year anniversary of January 10, 2020 and 1/48th of the shares vesting monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":111250,"derivative":{"exercise_price":27.42,"expiration_date":"2030-07-09","underlying":"Common Stock","underlying_shares":111250},"source":{"system":"sec-edgar","filing":"0001209191-20-042242","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919120042242/doc4.xml","form_type":"4"}},{"id":3266272,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-18T21:30:04.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":111250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vest on the one year anniversary of January 10, 2020 and 1/48th of the shares vesting monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":111250,"derivative":{"exercise_price":30,"expiration_date":"2030-01-09","underlying":"Common Stock","underlying_shares":111250},"source":{"system":"sec-edgar","filing":"0001209191-20-010143","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919120010143/doc4a.xml","form_type":"4/A","original_submission_date":"2020-01-13"}},{"id":3312435,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-13T23:57:44.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":111250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares vest on the one year anniversary of January 10, 2020 and 1/48th of the shares vesting monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":111250,"derivative":{"exercise_price":31.5,"expiration_date":"2030-01-09","underlying":"Common Stock","underlying_shares":111250},"source":{"system":"sec-edgar","filing":"0001209191-20-003223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919120003223/doc4.xml","form_type":"4"}},{"id":3312434,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-01-13T23:57:44.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The shares being reported are being issued pursuant to restricted stock unit awards (\"RSUs\"), each one of which represents a contingent right to receive one share of Issuer's common stock. 25% of the shares vest on each one-year anniversary of January 10, 2020."}],"balance_after":840274,"source":{"system":"sec-edgar","filing":"0001209191-20-003223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919120003223/doc4.xml","form_type":"4"}},{"id":3312433,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":33836,"kind":"person","name":"Shefferman Jesse","position":1,"cik":"0001799167","reported_name":"Shefferman Jesse","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-01-13T23:57:44.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":790274,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were received in exchange for i) 4,000,000 shares of ArTara Sub Common Stock; and ii) 142,857 shares of ArTara Sub Exchangeable Common Stock, in connection with the Merger."}],"balance_after":790274,"source":{"system":"sec-edgar","filing":"0001209191-20-003223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919120003223/doc4.xml","form_type":"4"}}]}